Alnylam Pharmaceuticals, Inc.

ONPATTRO

Manufacturer:

Alnylam Pharmaceuticals, Inc.

Onpattro HCPCS:

J0222

HCPCS Code Descriptor:

Injection, patisiran, 0.1 mg

Category:

J Code

Onpattro NDCs:

71336-1000-01

Primary Type:

Genetic Disorder

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Onpattro:

ONPATTRO is a Genetic Disorder drug manufactured by Alnylam Pharmaceuticals, Inc. and administered via the Intravenous route of administration. The J Code: J0222 is aligned to the drug ONPATTRO.

ACCESS PRICING AND MORE BY REGISTERING

J0222 Added Date:

October 1, 2019

J0222 Effective Date:

October 1, 2019

J0222 Termination Date:

HCPCS Active

Onpattro billing and coding information can be found through Alnylam Pharmaceuticals, Inc. at the link below:
Onpattro patient assistance information can be found through Alnylam Assist at the URL: https://www.alnylamassist.com/
ONPATTRO prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for ONPATTRO. Please check back in a few weeks.